After months of teasing on social media, Hailey Bieber 's Rhode lip liner—a.k.a. the Rhode Peptide Lip Shape —is finally here ...

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

A registration statement on Form S-1 (File No. 333-284225) relating to the offering has been filed with the Securities and Exchange Commission and became effective on January 30, 2025. The offering is ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Valentine's Day is the perfect time to pamper the ones you love — or yourself — with thoughtful beauty gifts that will make ...

Black perfume, fashion as home, upgraded pop-up lipsticks, dry skin treatment, volumizing lip gloss, olive oil for the body, ...

Metsera, Inc. (Nasdaq: MTSR) ("Metsera"), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone ...

Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its ...

It also distributes physiotherapy equipment; health screening devices; dietary supplements, nutritional health food, beauty cosmeceuticals, milk powder, and dried fruits; and collagen peptides and ...

It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, melanoma, ovarian, lung ...